Carl June (Brian Ach/Getty Images for TIME 100 Health Summit)

Carl June: ‘We can now con­clude that CAR-T cells can ac­tu­al­ly cure pa­tients’

A decade af­ter the first-ever pa­tients were in­fused with CAR-T, at least two of them re­main can­cer free and their ge­net­i­cal­ly mod­i­fied cells still ap­pear …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.